Peptide Chemistry's Contribution to the Treatment of the Majority of Serious Illnesses: Peptide Antitumors. | ||||
| Egyptian Journal of Chemistry | ||||
| Article 43, Volume 64, Issue 11, November 2021, Page 6555-6570 PDF (632.96 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejchem.2021.80960.4012 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Gaber O. Moustafa 
| ||||
| Peptide Chemistry Department, Chemical Industries Research Division, National Research Centre, 12622-Dokki, Cairo, Egypt. | ||||
| Abstract | ||||
| Cancer is still considered one of the most serious diseases threatening human life. In the past three decades, there enormous efforts have been undertaken to confront cancer diseases. Within such efforts, many therapeutic agents have been developed to treat cancer patients in their early, as well as late cancer-developing stages. These agents vary from antibiotics, chemically synthesized compounds, and natural products-based drugs. Proteins, peptides, and amino acids have been implicated in preventing the development of different types of cancer. For this, this review focuses on the reports regarding peptide compounds showing their biological activity especially as anti-cancer agents.For example: Bleomycin, Cryptophycin and its analogues, Bombesin, Bradykinin and prophyrin family. | ||||
| Keywords | ||||
| Peptide Chemistry; Illnesses; Peptide Antitumors | ||||
|
Statistics Article View: 202 PDF Download: 226 |
||||
